X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Nantahala Capital Management, LLC's stake in X4 Pharmaceuticals, Inc. fell to 2.80% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Nantahala Capital Management, LLC's stake in X4 Pharmaceuticals, Inc. fell to 2.80%, 2,449,468 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 2.80%
- Shares
- 2,449,468
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 2.80% | 2,449,468 |
| Wilmot B. Harkey | 2.80% | 2,449,468 |
| Daniel Mack | 2.80% | 2,449,468 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Nantahala Capital Management, LLC
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G · Nantahala Capital Management, LLC · Nov 14, 2025
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026